MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q900. A total of 3 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $639,170 | +29.1% | 79,400 | +74.1% | 0.00% | 0.0% |
| Q2 2023 | $495,216 | +137.7% | 45,600 | +51.0% | 0.00% | +100.0% |
| Q1 2023 | $208,380 | +86.3% | 30,200 | +7.5% | 0.00% | – |
| Q4 2022 | $111,838 | -35.7% | 28,100 | +7.7% | 0.00% | – |
| Q3 2022 | $174,000 | +370.3% | 26,100 | +239.0% | 0.00% | – |
| Q2 2022 | $37,000 | -53.2% | 7,700 | -9.4% | 0.00% | – |
| Q1 2022 | $79,000 | -92.0% | 8,500 | -89.8% | 0.00% | -100.0% |
| Q4 2021 | $987,000 | +10.9% | 83,100 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $890,000 | -36.2% | 78,200 | +0.5% | 0.00% | -50.0% |
| Q2 2021 | $1,396,000 | +257.9% | 77,800 | +208.7% | 0.00% | +100.0% |
| Q1 2021 | $390,000 | -41.3% | 25,200 | -53.7% | 0.00% | 0.0% |
| Q4 2020 | $664,000 | -45.7% | 54,400 | -42.9% | 0.00% | -75.0% |
| Q3 2020 | $1,223,000 | – | 95,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 49,500 | $40,913 | 0.02% |
| GROUP ONE TRADING, L.P. | 79,400 | $639,170 | 0.00% |
| SIMPLEX TRADING, LLC | 285,100 | $2,295 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 5,600 | $45,080 | 0.00% |
| JANE STREET GROUP, LLC | 42,000 | $338,100 | 0.00% |